Indoco Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 13,491.4 million compared to INR 12,113.1 million a year ago. Revenue was INR 13,748.4 million compared to INR 12,423 million a year ago. Net income was INR 757.7 million compared to INR 1,164.5 million a year ago. Basic earnings per share from continuing operations was INR 8.14 compared to INR 12.64 a year ago. Diluted earnings per share from continuing operations was INR 8.13 compared to INR 12.64 a year ago.